Cargando…

Current controversies in infective endocarditis

Infective endocarditis is a life-threatening disease caused by a focus of infection within the heart. For clinicians and scientists, it has been a moving target that has an evolving microbiology and a changing patient demographic. In the absence of an extensive evidence base to guide clinical practi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cahill, Thomas J., Prendergast, Bernard D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754014/
https://www.ncbi.nlm.nih.gov/pubmed/26918142
http://dx.doi.org/10.12688/f1000research.6949.1
_version_ 1782415961094094848
author Cahill, Thomas J.
Prendergast, Bernard D.
author_facet Cahill, Thomas J.
Prendergast, Bernard D.
author_sort Cahill, Thomas J.
collection PubMed
description Infective endocarditis is a life-threatening disease caused by a focus of infection within the heart. For clinicians and scientists, it has been a moving target that has an evolving microbiology and a changing patient demographic. In the absence of an extensive evidence base to guide clinical practice, controversies abound. Here, we review three main areas of uncertainty: first, in prevention of infective endocarditis, including the role of antibiotic prophylaxis and strategies to reduce health care-associated bacteraemia; second, in diagnosis, specifically the use of multimodality imaging; third, we discuss the optimal timing of surgical intervention and the challenges posed by increasing rates of cardiac device infection.
format Online
Article
Text
id pubmed-4754014
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-47540142016-02-24 Current controversies in infective endocarditis Cahill, Thomas J. Prendergast, Bernard D. F1000Res Review Infective endocarditis is a life-threatening disease caused by a focus of infection within the heart. For clinicians and scientists, it has been a moving target that has an evolving microbiology and a changing patient demographic. In the absence of an extensive evidence base to guide clinical practice, controversies abound. Here, we review three main areas of uncertainty: first, in prevention of infective endocarditis, including the role of antibiotic prophylaxis and strategies to reduce health care-associated bacteraemia; second, in diagnosis, specifically the use of multimodality imaging; third, we discuss the optimal timing of surgical intervention and the challenges posed by increasing rates of cardiac device infection. F1000Research 2015-11-18 /pmc/articles/PMC4754014/ /pubmed/26918142 http://dx.doi.org/10.12688/f1000research.6949.1 Text en Copyright: © 2015 Cahill TJ and Prendergast BD http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Cahill, Thomas J.
Prendergast, Bernard D.
Current controversies in infective endocarditis
title Current controversies in infective endocarditis
title_full Current controversies in infective endocarditis
title_fullStr Current controversies in infective endocarditis
title_full_unstemmed Current controversies in infective endocarditis
title_short Current controversies in infective endocarditis
title_sort current controversies in infective endocarditis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754014/
https://www.ncbi.nlm.nih.gov/pubmed/26918142
http://dx.doi.org/10.12688/f1000research.6949.1
work_keys_str_mv AT cahillthomasj currentcontroversiesininfectiveendocarditis
AT prendergastbernardd currentcontroversiesininfectiveendocarditis